Download Download this free, 150-page Pharmaceutical Serialization Playbook jam-packed with strategies for success and pitfalls to avoid.  Learn more >>
Article |

Type too small?

The Nonprescription Drug Manufacturers Assn. (NDMA) supports FDA's attempt to simplify OTC drug labels but called for greater flexibility in the proposed 6-point type size requirement.
Print Reprint
FILED IN:  Applications  > Healthcare  > Pharmaceutical

NDMA estimates that over 30% of national OTC brand name products and 95% of store brand packages have small sizes or nontraditional shapes that aren't big enough to permit regulatory copy in 6-point type. Drug manufacturers NDMA said are doing their best to maximize type size without going below 4.5-point type.

Related Sponsored Content

The 2014 Packaging Trends Report
Sign up to receive timely updates from our editors and download this e-book consisting of our editors' picks of most notable package designs. Updated for 2014!


Don't miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!
Each newsletter ranges in frequency from once per month to a few times per month at most.